Company Profile:
ABBVIE HEALTHCARE INDIA PRIVATE LIMITED primarily functions as a commercial, marketing, sales, and distribution entity for AbbVie's global pharmaceutical products in India. It acts more as a trader or distributor rather than a manufacturing factory.
Company Profile
Nature of Business: Commercial, Marketing, Sales, and Distribution of Pharmaceutical Products.
Introduction:
ABBVIE HEALTHCARE INDIA PRIVATE LIMITED is the Indian affiliate of AbbVie Inc., a leading global biopharmaceutical company headquartered in the United States. The company is dedicated to developing and delivering innovative medicines that address serious health issues and have a remarkable impact on people's lives.
Role in India:
The primary role of ABBVIE HEALTHCARE INDIA PRIVATE LIMITED in India is to manage the commercial operations for AbbVie's diverse portfolio of pharmaceutical products. This includes the import, marketing, sales, and distribution of medicines developed and manufactured by AbbVie globally. The Indian entity ensures that these innovative therapies are available to patients and healthcare providers across India.
Therapeutic Areas:
AbbVie's global product portfolio spans several key therapeutic areas, which are also the focus for the Indian market. These typically include:
Immunology
Oncology
Neuroscience
Eye Care
Virology
Aesthetics
Business Model:
While the parent company, AbbVie Inc., conducts extensive research, development, and manufacturing of pharmaceutical products worldwide, ABBVIE HEALTHCARE INDIA PRIVATE LIMITED itself does not operate manufacturing facilities in India. Instead, it serves as the local commercial arm responsible for market access, sales force management, medical affairs, regulatory compliance, and patient support programs related to AbbVie's globally produced drugs within the Indian subcontinent. It acts as a crucial link in the supply chain, facilitating the trade and availability of high-quality, innovative medicines to the Indian population.
Enterprise Products
Here are some products manufactured or marketed by ABBVIE HEALTHCARE INDIA PRIVATE LIMITED:
* HUMIRA (adalimumab)
* DUOPA (carbidopa and levodopa)
* CREON (pancrelipase)
* MAVYRET (glecaprevir and pibrentasvir)
* BOTOX (onabotulinumtoxinA)
Please note that this list may not be exhaustive and could change over time. It's recommended to check AbbVie India's official website or other reliable sources for the most up-to-date product information.